Overview

Bupivicaine to Reduce Postoperative Pain in Laparoscopic Ventral Hernia Repair

Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators are testing to see if infusion of bupivicaine between the mesh and abdominal wall can reduce postoperative pain and decrease use of narcotics in the postoperative setting.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chang, Steve S., M.D.
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

1. Patient must be scheduled for a laparoscopic ventral hernia repair at SBCH. If any
additional procedure is performed, the subject will be excluded from the study

2. Age 18 or older

3. Patient must agree to complete pain journal postoperatively

4. Informed consent signed and dated by patient. Consenting through a legally authorized
guardian will not be accepted due to the necessity of completing a subjective pain
journal

Exclusion Criteria:

1. Any surgical procedure occurring besides the study procedure

2. Any allergy or sensitivity to bupivicaine or its derivatives

3. Less than 18 years of age

4. Patient unable to self report in pain journal due to cognitive disabilities

5. Discharged less than 4 hours post-surgery